SCHEDULE 13D

Company

Adicet Bio, Inc.

Filed

February 2, 2018

Accession Number

0000947871-18-000091

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →